Evidence map›Paper›PMID 36994009›Full record

ArticleJournal of family medicine and primary care2022

Sputum antibiogram in acute exacerbation of chronic obstructive pulmonary disease.

Rekha Manjhi, Sushant Kumar Nanda, Babul Kumar Agrawal

Abstract read
In one paragraph

Article in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rekha ManjhiDepartment of Pulmonary Medicine, VSS Institute of Medical Science and Research, Sambalpur University, Burla, Odisha, India.
Sushant Kumar NandaDepartment of Pulmonary Medicine, VSS Institute of Medical Science and Research, Sambalpur University, Burla, Odisha, India.
Babul Kumar AgrawalDepartment of Pulmonary Medicine, VSS Institute of Medical Science and Research, Sambalpur University, Burla, Odisha, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bacterial infections are the most common reason for acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This can range from self-limited disease to respiratory failure requiring mechanical ventilation and is associated with increased mortality and morbidity in survivors. Aim: To ascertain common antibiotics effective in AECOPD using sputum bacterial culture and antibiotic susceptibility testing. Materials and Methods: In the present cross-sectional observational study, we analysed the sputum antibiogram in 237 patients who had not received antibiotics in the past 48 hours. Statistical analysis was performed, and the χ Results: Of 237 sputum samples, 77.2% were mucoid in nature, followed by purulent and mucopurulent sputum in 16.9% and 5.9% of cases, respectively. In the purulent/mucopurulent samples, 85.2% showed positive growth on culture compared to 35% of mucoid samples. Cultures grew single pathogens in 108 cases, and 2 grew multiple pathogens; in 127 cases, no pathogenic organisms were isolated. In all, 41 (37.96%) isolates grew Gram-positive and 67 (62.04%) grew Gram-negative organisms. The most effective antibiotic against Gram-negative bacteria was imipenem (50%) and that against Gram-positive bacteria was vancomycin (70.59%). All isolates were resistant to ampicillin. Conclusion: Sputum culture is a good and simple tool to study the aetiology and complications caused by bacteria in AECOPD. The antibiogram helps in identifying the correct treatment and timely initiation of appropriate antimicrobial therapy, thereby helping reduce mortality and morbidity.

Indexed as

Mechanical ventilationpulmonary infectionsrespiratory failuresputum culture

Identifiers

PMID36994009
PMCPMC10041001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.